Cullgen Inc
A strategic Regulatory Consultant will manage risk and drive programs forward within a small-company environment to support the development and commercialization of a therapeutic pipeline. The role involves compiling regulatory submissions, overseeing quality functions, and serving as the primary contact with health authorities like the FDA.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2018
Cullgen is a biopharmaceutical company focused on developing targeted protein degraders and Degrader-Antibody Conjugates (DACs) for the treatment of cancer, pain, and inflammatory diseases. The company's platform specializes in drugging previously 'undruggable' targets through protein degradation. Cullgen was acquired by Gyre Therapeutics in 2026 to form a fully integrated U.S.- and China-based biopharmaceutical company.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cullgen Inc.
Cullgen Inc didn’t post a salary, so this is our estimate from similar listings.
Senior Manager, Regulatory Affairs US & Canada Strategy Lead – Therapeutic Neurotoxins - Hybrid
AbbVie
Regulatory affairs Manager
Integrated Resources INC
Director Regulatory Affairs
Houston Methodist
Associate Director, Regulatory Affairs US Lead, Regulatory Science & Execution
AstraZeneca
Senior Manager, Regulatory Affairs US & Canada Strategy Lead – Aesthetics Device (Hybrid)
AbbVie
Senior Regulatory Affairs Scientist
Venesco